CRISPR-based editing strategies to rectify EYA1 complex genomic rearrangement linked to haploinsufficiency
Yi, H.; Yun, Y.; Choi, W. H.; Hwang, H.-Y.; Cha, J. H.; Seok, H.; Song, J.-J.; Lee, J. H.; Oh, S. H.; Lee, S.-Y.; Kim, D.
Show abstract
Pathogenic structure variations (SVs) and genomic rearrangements are associated with various types of cancer and rare genetic diseases. Recent studies have used Cas9 nuclease with paired guide RNAs (gRNAs) to generate targeted chromosomal rearrangements. Studies on Cas9-mediated translocations and inversions have mainly focused on producing fusion proteins that cause cancer, whereas research on precision genome editing for rectifying SVs is limited. In this study, through whole- genome sequencing, we identified a novel complex genomic rearrangement (CGR), specifically an EYA1 inversion with a deletion, implicated in branchio-oto- renal/branchio-oto (BOR/BO) syndrome. The CGR results in a loss-of-function allele, leading to haploinsufficiency. To address this, two CRISPR-based editing approaches were tested. First, we engineered Cas9 nuclease and paired gRNAs tailored to the patients genome. The dual CRISPR/Cas9 system induced efficient editing at sites with paracentric inversion in patient-derived fibroblasts (up to 1.6%), and effectively restored the expression levels of the EYA1 gene and its downstream targets, restoring overall transcriptional functionality. Additionally, we engineered gene-activating CRISPR-Cas modules (CRISPRa), which increased EYA1 mRNA and protein expression to wild-type levels in human EYA1 monoallelic knockout cells that mimic the haploinsufficiency. Moreover, CRISPRa significantly improved transcriptional activity essential for target gene expression. This suggests that CRISPRa-based gene therapies may offer substantial translational potential for approximately 70% of disease-causing EYA1 variants responsible for haploinsufficiency. In parallel to deciphering the complexities of the genomic landscape related to human genetic disorders, our findings demonstrate the potential of CIRSPR-guided genome editing for correcting SVs, including those with EYA1 CGR linked to haploinsufficiency.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Loss-of-function of the Zinc Finger Homeobox 4 ( ZFHX4 ) gene underlies a neurodevelopmental disorder 95%
- High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiency 95%
- Rare variants in PRKCI cause Van der Woude syndrome and other features of peridermopathy 95%
Similar papers in this journal
- A novel RLIM/RNF12 variant disrupts protein stability and function to cause severe Tonne-Kalscheuer syndrome 96%
- Massively parallel identification of functionally consequential noncoding genetic variants in undiagnosed rare disease patients 95%
- Full characterization of unresolved structural variation through long-read sequencing and optical genome mapping 94%
Similar papers in this journal
- Long-read genome sequencing for the diagnosis of neurodevelopmental disorders 95%
- Identification and validation of novel candidate risk genes in endocytic vesicular trafficking associated with esophageal atresia and tracheoesophageal fistulas 95%
- Functional characterization of pathogenic SATB2 missense variants identifies distinct effects on chromatin binding and transcriptional activity 94%
Similar papers in this journal
- Comprehensive reanalysis for CNVs in ES data from unsolved rare disease cases results in new diagnoses 94%
- Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort 93%
- Whole genome sequencing delineates regulatory and novel genic variants in childhood cardiomyopathy 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.